SCHEMBL27900413

SCHEMBL27900413

O=C(O)c1cccc(CCCl)c1[N+](=O)[O-]

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.45
HMGB1 P09429 1/20 0.41
FOLH1 Q04609 2/20 0.41
CDK2 P24941 2/20 0.40
ALDH1A1 P00352 4/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
MAPT P10636 2/20 0.39
PLA2G1B P04054 1/20 0.39
ATG4B Q9Y4P1 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP3A4 P08684 1/20 0.38
HPGD P15428 2/20 0.37
TP53 P04637 1/20 0.37
ALOX15 P16050 1/20 0.36
CYP2D6 P10635 1/20 0.36
POLB P06746 1/20 0.36
HSP90AA1 P07900 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2053816 0.87 ALDH1A1 (0.49) TSHRHMGB1FOLH1CDK2ALDH1A1
SCHEMBL27535973 0.85 ALDH1A1 (0.47) TSHRHMGB1FOLH1CDK2ALDH1A1
SCHEMBL28638919 0.84 TSHR (0.43) TSHRHMGB1FOLH1CDK2ALDH1A1
SCHEMBL27969733 0.84 HMGB1 (0.61) TSHRHMGB1FOLH1CDK2ALDH1A1
SCHEMBL3387371 0.84 TSHR (0.49) TSHRHMGB1FOLH1ALDH1A1CYP1A2
SCHEMBL29163236 0.84 HMGB1 (0.45) TSHRHMGB1FOLH1CDK2ALDH1A1
SCHEMBL27574811 0.84 TSHR (0.45) TSHRHMGB1FOLH1CDK2ALDH1A1
SCHEMBL28471763 0.83 ALDH1A1 (0.48) TSHRFOLH1CDK2ALDH1A1MEN1
SCHEMBL27957680 0.83 TSHR (0.44) TSHRHMGB1FOLH1CDK2ALDH1A1
SCHEMBL1523175 0.81 TSHR (0.53) TSHRHMGB1FOLH1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103080107-A Heteroaryl compounds and compositions as protein kinase inhibitors NOVARTIS AG 2013-05-01 CN disclosed